AI assistant
CONMED Corp — Director's Dealing 2018
May 25, 2018
31971_dirs_2018-05-25_0167d89d-1f26-4e15-8232-795708662169.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2018-05-23
Reporting Person: Pelletier Johonna Marie (Treasurer and VP, Tax)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2982 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options To Purchase Common Stock | $39.87 | 2026-03-01 | Common Stock (9500) | Direct | |
| Options To Purchase Common Stock | $41.93 | 2027-03-01 | Common Stock (10000) | Direct | |
| Options To Purchase Common Stock | $59.96 | 2028-03-01 | Common Stock (13500) | Direct | |
| Rsus (restricted Stock Units) | $0 | 2023-06-01 | Common Stock (880) | Direct | |
| Rsus (restricted Stock Units) | $0 | 2024-06-01 | Common Stock (390) | Direct | |
| Rsus (restricted Stock Units) | $0 | 2025-02-27 | Common Stock (250) | Direct | |
| Rsus (restricted Stock Units) | $0 | 2026-03-01 | Common Stock (250) | Direct | |
| Sars (Stock Appreciation Rights) | $51.30 | 2025-02-27 | Common Stock (4000) | Direct |
Footnotes
F1: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year after the grant date and 15% vesting in the sixth and seventh year.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
F4: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F5: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F6: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.